1ST EP1
Alternative Names: 1ST-EP1Latest Information Update: 22 Jan 2025
Price :
$50 *
At a glance
- Originator 1St Biotherapeutics
- Class Antibodies; Antineoplastics; Drug conjugates; Immunoconjugates
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer
Most Recent Events
- 19 Dec 2024 Early research in Cancer in South Korea (Parenteral) prior to December 2024 (1St Biotherapeutics pipeline; December 2024)